Luca Facchini
Academy for Urban School Leadership
22 Papers
96 Citations
Luca Facchini is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Medicine & Thrombotic microangiopathy. The author has an hindex of 9, co-authored 18 publications. Previous affiliations of Luca Facchini include University of Modena and Reggio Emilia.
Chat about Author
Papers
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
Cristina Cattaneo,R Di Blasi,Cristina Skert,Anna Candoni,Bruno Martino,N. Di Renzo,Mario Delia,Stelvio Ballanti,Francesco Marchesi,Valentina Mancini,Enrico Orciuolo,Simone Cesaro,Lucia Prezioso,Rosa Fanci,Gianpaolo Nadali,Anna Chierichini,Luca Facchini,Marco Picardi,Michele Malagola,Vincenza Orlando,Enrico Maria Trecarichi,Mario Tumbarello,Franco Aversa,Giorgio Rossi,Livio Pagano,Angela Passi,Doriana Gramegna,Domenico Russo,Davide Lazzarotto,Domenico Rotilio,Maria Rosaria De Paolis,Edoardo Simonetti,Maria Alessandra Innocente,Antonio Spadea,Francesco Mazziotta,Anna Pegoraro,Angelica Spolzino,Gloria Turri,Barbara Veggia +38 more
TL;DR: MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRrel BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in CR-rel BSIs.
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms : an European Leukemia Net study
Ida Martinelli,Valerio De Stefano,Alessandra Carobbio,Maria Luigia Randi,Claudia Santarossa,Alessandro Rambaldi,Maria Chiara Finazzi,Francisco Cervantes,Eduardo Arellano-Rodrigo,Serena Rupoli,Lucia Canafoglia,Alessia Tieghi,Luca Facchini,Silvia Betti,Alessandro M. Vannucchi,Lisa Pieri,Rossella R. Cacciola,Emma Cacciola,Agostino Cortelezzi,Alessandra Iurlo,Enrico Pogliani,Elena Maria Elli,Antonio Spadea,Tiziano Barbui +23 more
TL;DR: CVT and unprovoked event were the only predictive variables in a multivariate model including also sex, blood count, thrombophilia, cytoreductive, and antithrombotic treatment.
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment
Monica Morselli,Mario Luppi,Leonardo Potenza,Luca Facchini,Stefania Tonelli,Daniele Dini,Giovanna Leonardi,Amedea Donelli,Franco Narni,Giuseppe Torelli +9 more
TL;DR: The disease presents with severe hemolysis, responds to steroids, but usually runs a chronic course of disease.
41
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
Elisabetta Todisco,Cristina Papayannidis,Nicola Stefano Fracchiolla,Elisabetta Petracci,Chiara Zingaretti,Calogero Vetro,Maria Paola Martelli,Patrizia Zappasodi,Nicola Di Renzo,Susanna Gallo,Ernesta Audisio,Davide Griguolo,Claudio Cerchione,Carmine Selleri,Daniele Mattei,Massimo Bernardi,Monica Fumagalli,Giuliana Rizzuto,Luca Facchini,Claudio Basilico,Ilenia Manfra,Erika Borlenghi,Roberto Cairoli,Prassede Salutari,Michele Gottardi,Alfredo Molteni,Vincenza Martini,Monia Lunghi,Luana Fianchi,Daniela Cilloni,Francesco Panza,Elisabetta Abruzzese,Nicola Cascavilla,F. Rivellini,Felicetto Ferrara,Luca Maurillo,Jacopo Nanni,Alessandra Romano,Valeria Cardinali,Federica Gigli,Elisa Roncoroni,Vincenzo Federico,Giovanni Marconi,R. Volpi,Mariarita Sciumè,Corrado Tarella,Giuseppe Rossi,Giovanni Martinelli +47 more
TL;DR: Venetoclax in combination with hypomethylating agents (HMA) is revolutionizing the therapy of acute myeloid leukemia (AML), however, evidence on large sets of patients is lacking, especially in relapsed or refractory leukemia as mentioned in this paper .
24
Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
Licia Iaccarino,Mariadomenica Divona,Tiziana Ottone,Laura Cicconi,Serena Lavorgna,Claudia Ciardi,Valentina Alfonso,Serena Travaglini,Luca Facchini,Giuseppe Cimino,Eros Di Bona,Maria Teresa Voso,Francesco Lo-Coco +12 more
TL;DR: This study indicates that an integrated laboratory approach, employing several diagnostic techniques is crucial to timely diagnose APL, and designed a patient‐specific quantitative real‐time PCR for the atypical transcripts, which allowed for specific quantitative evaluation of minimal residual disease (MRD) during follow‐up.
18